logo BDSP

Base documentaire

  1. Valuation of the benefits of risk-free blood: willingness to pay for hemoglobin solutions.

    Article - En anglais

    Disease-free hemoglobin solutions will be commercially available in 1991.

    A willingness-to-pay (WTP) survey was undertaken to assess the tangible and intangible benefits to the public from this new product.

    The positive results suggest that third-party payers should cover this benefit and assist the diffusion of this new technology.

    Mots-clés Pascal : Constituant sang, Analyse risque, Opinion publique, Analyse avantage coût, Transfusion, Economie santé

    Mots-clés Pascal anglais : Blood product, Risk analysis, Public opinion, Cost benefit analysis, Transfusion, Health economy

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 91-0412828

    Code Inist : 002B27B16A. Création : 199406.